[1] Merin, E., Vanijcharoenkarn, K., Shih, J. A., & Eun- Hyung Lee, F. (2019). Epidemiology and risk factors for asthma. Respiratory Medicine, 149, P16–P22. https://doi.org/10.1016/j.rmed.2019.01.014

[2] Asher, M. I., Rutter, C. E., Bissell, K., Chiang, C. Y., El Sony, A., Ellwood, E., Ellwood, P., García- Marcos, L., Marks, G. B., Morales, E., Mortimer, K., Pérez-Fernández, V., Robertson, S., Silverwood, R. J., Strachan, D. P., Pearce, N., Bissell, K., Chiang, C.-Y., Ellwood, E.,... Shah, J., & the Global Asthma Network Phase I Study Group. (2021, October 30). Worldwide trends in the burden of asthma symptoms in schoolaged children: Global Asthma Network Phase I cross-sectional study. Lancet, 398(10311), 1569– 1580. https://doi.org/10.1016/S0140-6736(21)01450-1

[3] Kips, J. C., Anderson, G. P., Fredberg, J. J., Herz, U., Inman, M. D., Jordana, M., Kemeny, D. M., Lötvall, J., Pauwels, R. A., Plopper, C. G., Schmidt, D., Sterk, P. J., Van Oosterhout, A. J., Vargaftig, B. B., & Chung, K. F. (2003). Murine models of asthma. The European Respiratory Journal, 22(2), 374–382. https://doi.org/10.1183/09031936.03.00026403

[4] Hellings, P. W., Hessel, E. M., Van Den Oord, J. J., Kasran, A., Van Hecke, P., & Ceuppens, J. L. (2001). Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen. Clinical and Experimental Allergy, 31(5), 782–790. https://doi.org/10.1046/j.1365-2222.2001.01081.x

[5] Park, H. S., & Nahm, D. H. (1996). Isocyanate-induced occupational asthma: Challenge and immunologic studies. Journal of Korean Medical Science, 11(4), 314–318. https://doi.org/10.3346/jkms.1996.11.4.314

[6] Butcher, B. T., & Salvaggio, J. E. (1986). Occupational asthma. The Journal of Allergy and Clinical Immunology, 78(4 Pt 1), 547–556. https://doi.org/10.1016/0091- 6749(86)90068-0

[7] Scheerns, H., Buckley, T. L., Muis, T., Van Loveren, H., & Nijkamp, F. P. (1996). The involvement of sensory neuropeptides in toluene diisocyanateinduced tracheal hypersensitivity in mouse airways. British Journal of Pharmacology, 119(8), 1665–1671.

[8] Vanoirbeek, J. A., Tarkowski, M., Vanhooren, H. M., De Vooght, V., Nemery, B., & Hoet, P. H. (2006). Validation of a mouse model of chemicalinduced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. The Journal of Allergy and Clinical Immunology, 117(5), 1090–1097. https://doi.org/10.1016/j.jaci.2006.01.027

[9] Jung, K. S., & Park, H. S. (1999). Evidence for neutrophil activation in occupational asthma. Respirology, 4(3), 303–306. https://doi.org/10.1046/j.1440- 1843.1999.00196.x

[10] Osadchuk, L. V., Bragin, A. V., & Osadchuk, A. V. (2009). [Interstrain differences in social and time patterns of agonistic behavior in male laboratory mice]. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova, 59(4), 473–481.

[11] Herrick, C. A., Xu, L., Wisnewski, A. V., Das, J., Redlich, C. A., & Bottomly, K. (2002). A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. The Journal of Allergy and Clinical Immunology, 109, 873–878. https://doi.org/10.1067/mai.2002.123533

[12] Lee, Y. C., Song, C. H., Lee, H. B., Oh, J. L., Rhee, Y. K., Park, H. S., & Koh, G. Y. (2001). A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor. The Journal of Allergy and Clinical Immunology, 108, 1021–1026. https://doi.org/10.1067/mai.2001.120132

[13] Lee, Y. C., Kwak, Y. G., & Song, C. H. (2002). Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. The Journal of Immunology, 168, 3595– 3600. https://doi.org/10.4049/jimmunol.168.7.3595

[14] Matheson, J. M., Lange, R. W., Lemus, R., Karol, M. H., & Luster, M. I. (2001). Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI). Clinical and Experimental Allergy, 31, 1067–1076. https://doi.org/10.1046/j.1365-2222.2001.01125.x

[15] Scheerens, H., Buckley, T. L., Muis, T. L., Garssen, J., Dormans, J., Nijkamp, F. P., & Van Loveren, H. (1999). Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. American Journal of Respiratory and Critical Care Medicine, 159, 1074– 1080. https://doi.org/10.1164/ajrccm.159.4.9701012

[16] Okada, S., Hasegawa, S., Hasegawa, H., Ainai, A., Atsuta, R., Ikemoto, K., Sasaki, K., Toda, S., Shirabe, K., Takahara, M., Harada, S., Morishima, T., & Ichiyama, T. (2013). Analysis of bronchoalveolar lavage fluid in a mouse model of bronchial asthma and H1N1 2009 infection. Cytokine, 63(2), 194–200. https://doi.org/10.1016/j.cyto.2013.04.035

[17] Świerczyńska-Machura, D., Walusiak-Skorupa, J., Nowakowska-Świrta, E., Piasecka-Zelga, J., Świercz, R., & Pałczyński, C. (2012). Immunological determinants in a murine model of toluene diisocyanateinduced asthma. International Journal of Occupational Medicine and Environmental Health, 25(4), 492–498. https://doi.org/10.2478/s13382-012-0063-1